Extractable Nuclear Antigens
Mostrando 1-12 de 21 artigos, teses e dissertações.
-
1. AnticorpoS IgG e IgE para auto-antígenos nucleares no Lúpus eritematoso sistêmico.
O Lúpus Eritematoso Sistêmico (LES) é uma doença reumática autoimune, classificada como uma reação de hipersensibilidade tipo III, que cursa com exuberante produção de auto-anticorpos de diferentes especificidades, e reação inflamatória crônica. O LES acomete predominantemente pessoas do sexo feminino, com prevalência de 5-50 casos/100.000. Con
Publicado em: 2005
-
2. Autoantibodies to Extractable Nuclear Antigens: Making Detection and Interpretation More Meaningful
American Society for Microbiology.
-
3. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).
Clinical and biological manifestations have been studied in 134 patients whose serum had antibodies to soluble extractable nuclear antigens (ENA). 85 of the patients had anti-RNP antibodies, 18 had anti-Sm antibodies, and 31 had antibodies to one or more soluble nuclear antigen. In all groups, the predominant clinical manifestations were polyarthritis, Rayna
-
4. Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.
Antibodies to different components of the extractable nuclear antigen (ENA) have been thought to be serological markers for clinical subsets of rheumatic diseases. However, incomplete characterization and standardization of antigenic components such as ribonucleoprotein (RNP), Sm, and SS-B (Ha), and the multiplicity of autoantibodies produced by different pa
-
5. Autoantibody profile in juvenile chronic arthritis.
Patients with juvenile chronic arthritis (JCA) may be subdivided into a minority, who carry IgM rheumatoid factor and have erosive polyarthritis resembling adult rheumatoid arthritis, and the majority (90%), who are seronegative by conventional means. Between 30 and 60% of patients with JCA have positive antinuclear antibodies (ANAs) according to the choice
-
6. High-Quality, Cost-Effective Strategy for Detection of Autoantibodies to Extractable Nuclear Antigens
We evaluated methods for the detection of autoantibodies to extractable nuclear antigens (ENAs) to determine the strategy that yielded the most cost effective and clinically meaningful result. We prospectively compared counterimmunoelectrophoresis (CIEP) with and without serum prediffusion (SPD) and found that SPD significantly improved the quality of precip
American Society for Microbiology.
-
7. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes.
Antibodies which bind to different nuclear antigens in tissue sections or in permeabilized cell cultures are useful markers of subsets of connective tissue disease, especially of lupus erythematosus (LE), but whether these antibodies are able to react with these intracellular sequestered antigens in vivo and cause immunologic tissue damage has been a matter
-
8. Practical Evaluation of Methods for Detection and Specificity of Autoantibodies to Extractable Nuclear Antigens
Detection and specificity of autoantibodies against extractable nuclear antigens (ENA) play a critical role in the diagnosis and management of autoimmune disease. Historically, the detection of these antibodies has employed double immunodiffusion (DID). Autoantibody specificity was correlated with diagnoses by this technique. Enzyme immunoassays have been de
American Society for Microbiology.
-
9. Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens.
Serum samples from 55 patients with systemic lupus erythematosus (SLE) were selected for the absence of anti-extractable nuclear antigen antibodies after routine immunodiffusion tests. These sera were immunoblotted for anti-Sm and anti-RNP antibodies on a HeLa cell nuclear extract. Ten (18%) were negative and 45 (82%) produced complex patterns: 10 (18%) sugg
-
10. Sjögren's syndrome and fibrosing alveolitis complicated by pulmonary lymphoma.
The case of a middle aged woman who presented with fibrosing alveolitis, in her mid-forties, followed by a sicca syndrome and who subsequently developed a pulmonary lymphoma (B cell) while receiving azathioprine therapy is recorded. Of interest was the absence of polyclonal B cell activation, e.g., production of rheumatoid factor, hypergammaglobulinaemia, hi
-
11. Cellular immunity in systemic lupus erythematosus as evidenced in vitro by leucocyte migration inhibition tests.
A leucocyte migration inhibition test was performed on 26 patients with systemic lupus erythematosus (SLE) and on 35 control subjects using three different antigens, fetal calf thymus DNA, baker's yeast RNA, and calf thymus extractable nuclear antigen (ENA). Leucocyte migration was inhibited by DNA in 17 out of 26 SLE patients (65-3%), and in only 2 of the 3
-
12. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy
Using a hemagglutination test which can detect antibodies to (a) native and denatured deoxyribonucleic acid (DNA) and (b) an extractable nuclear antigen (ENA), a comparative study of patterns of autoantibody formation has been done in systemic lupus erythematosus (SLE) and related rheumatic diseases. Antibody to native DNA was present in the serum in 96% of